Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Canada (1)
Advocacy (policy advocacy, lobbying)
Musculoskeletal/Multiple Sclerosis (MS) (1)
Government (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Clinical study phase III